By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Grunenthal GmbH 

Pascalstraße 6

Aachen    52076  Germany
Phone: 0241-569-1111 Fax: 0241-569-1112



Company News
AcelRx Pharmaceuticals (ACRX), Grunenthal GmbH Strike Deal Worth $250 Million For Pain Treatment Drug 12/16/2013 9:42:18 AM
Grunenthal GmbH Expands Use of BioClinica, Inc.'s Next Generation Trident IWR/IVR for Global Trial 6/21/2013 9:25:23 AM
EFIC-Grünenthal-Grant Awards Seven Innovative Research Projects 6/6/2013 9:46:45 AM
Grunenthal GmbH Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN) 5/22/2013 9:55:09 AM
Grunenthal GmbH Highlights Significant R&D Advances in Pain, Inflammation as well as INTAC® Tamper-Resistant Technology at World's Largest Biotechnology Conference 4/19/2013 7:40:46 AM
Grunenthal GmbH to Present Data for Its Innovative Formulation Technology INTAC® at PAINWeek 2012 9/6/2012 10:15:58 AM
Grunenthal GmbH to Present Its Tamper Resistant Formulation Technology INTAC® at the Meeting & Exposition of the Controlled Release Society 7/13/2012 10:27:11 AM
Horizon Pharma, Inc. Enters into Exclusive Agreement with Grunenthal GmbH for Commercialization of DUEXIS® in Latin America 6/19/2012 11:37:11 AM
Grunenthal GmbH to Present at 2012 Biotechnology Industry Organization (BIO) International Convention on June 20, 2012, in Boston MA, US 6/15/2012 10:26:09 AM
Grunenthal GmbH Presents Strong Pipeline at World's Largest Biotechnology Conference 6/14/2012 11:17:45 AM